cro.directory
← Compare landing

Oncodesign Services vs TRiCBIO

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/oncodesign-services/tricbio

CategoryOncodesign ServicesTRiCBIO
Listed sitecrocro
SummaryContract research organization specializing in drug discovery and preclinical services for oncology, inflammation, and infectious diseases since 1995.TRiCBIO provides human organoid research services for efficacy, safety, mechanism and immune-context studies using PDO 2.0 and ALI platforms, supporting biopharma and CRO teams in candidate evaluation and translational research.
Services
  • Discovery Research
  • Target Identification & Validation
  • Medicinal Chemistry
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • In Vivo PK / PD Studies
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Specialized & Large-Animal Models
  • Bioanalysis
  • Immunogenicity Assays (ADA / NAb)
  • Biomarker Assays
  • Clinical Imaging Core Lab
  • Oncology Specialty Services
  • Immunology & Inflammation Services
  • Virology Services
  • GLP Toxicology
  • Safety Pharmacology
  • Translational Research
  • Preclinical In Vitro Studies
  • Regulatory Affairs
  • LC-MS Bioanalysis (Small Molecule)
  • High-Throughput Screening
  • Genetic Toxicology
  • Computational & In-Silico Drug Discovery
  • Carcinogenicity Studies
  • DART (Reproductive & Developmental Toxicology)
  • Flow Cytometry Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • Ligand-Binding Bioanalysis (Large Molecule)
  • Translational Research
  • In Vitro Pharmacology
  • In Vitro ADME / DMPK
  • Target Identification & Validation
  • Discovery Research
  • Medicinal Chemistry
  • Biomarker Assays
  • Flow Cytometry Services
Modalities
  • Small Molecule
  • Biologics (Other)
  • Antibody-Drug Conjugate (ADC)
  • Radiopharmaceutical
  • Antibody-Drug Conjugate (ADC)
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
Indications
  • Oncology
  • Immunology
  • Infectious Disease
  • Dermatology
  • Gastroenterology
  • Nephrology
  • Metabolic
  • Rare Disease
  • Respiratory
  • Oncology
  • Immunology
  • Rare Disease
  • Gastroenterology
Locations
  • Headquarters, Dijon, Bourgogne-Franche-Comté, France
  • Headquarters
  • Nanjing, Nanjing, China
  • Shanghai, Shanghai, China
  • Philadelphia, Philadelphia, Pennsylvania, United States
CertificationsData not yet provided.Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.